Login

Christoph Vilanek is the CEO of Freenet. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Lessons from Archegos: Octavio Marenz on Credit Suisse’s $4.7 Billion Loss | Octavio Marenz – Founder & CEO, Opimas
00:10:00
Navigating Market Waves: Insights from Robert Kelly on Elliott Wave Setups and ETF Strategies | Robert Kelly - Editor, U.S. Intraday Stocks Pro Service, Elliott Wave International
00:10:00
Riverside fosters long-term growth through fundamental operating improvements and add-on acquisitions|Pam Hendrickson, Vice Chairman, The Riverside Company
00:10:00
support early-stage startups as they need|Garrett Camp,Founding Partner,Expa
00:10:00
The Role of Public and Private Strategies in Real Estate: Insights from J.P. Morgan's Strategic Investment Advisory Group
00:10:00
Jim Mattis on Leadership: Insights from a Marine Corps General|Jim Mattis
00:10:00
Globant's CEO and Co-Founder, Martín Migoya, celebrates 20 years of leading innovation and success.
00:10:00
Redefining Financial Advisory: Beyond Investments | Alex Johnson, Founder and Financial Advisor, Oakview Wealth Management
00:10:00
Introducing Landis & Morningstar: Secure, Insightful Portfolio Management
00:10:00
Olivia Lum: President of Hyflux, leading water and environmental solutions company based in Singapore.
00:10:00
The problem is that it’s hard to assess management without being able to look them in the eye and ask the questions that matter to you|Paddy Nicol, President, CEO and Director of Orogen Royalties Inc
00:10:00
Panorama Minerals: Advancing Copper Exploration Projects in Peru

© 2017 - Neuhu+